RAPT Therapeutics, Inc.
RAPT
$31.85
-$0.48-1.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.36% | -2.78% | 67.76% | -188.89% | 33.37% |
| Total Depreciation and Amortization | -10.09% | -9.52% | -12.20% | -3.37% | -2.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.47% | -5.68% | -2.24% | 1.02% | -11.95% |
| Change in Net Operating Assets | -92.22% | 104.65% | -205.70% | 1,027.80% | 32.13% |
| Cash from Operations | -10.53% | 78.50% | -402.19% | 40.77% | 37.41% |
| Capital Expenditure | 100.00% | 6.98% | -4,200.00% | 94.12% | -1,800.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 217.24% | 87.34% | -6,672.09% | -104.56% | -3.90% |
| Cash from Investing | 216.60% | 87.28% | -6,669.16% | -104.57% | -4.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -77.64% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -77.64% | -- | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.47% | 83.22% | -183.04% | 15,918.83% | 109.99% |